Allogeneic Hematopoietic Stem Cell Transplantation (Allo-SCT) Versus Conventional Postremission Therapy (PRT) for AML in First Complete Remission (CR1): A Matched Pairs Analysis Based on Data of the AML Cooperative Group (AMLCG) 1999 Trial.
Title:
Allogeneic Hematopoietic Stem Cell Transplantation (Allo-SCT) Versus Conventional Postremission Therapy (PRT) for AML in First Complete Remission (CR1): A Matched Pairs Analysis Based on Data of the AML Cooperative Group (AMLCG) 1999 Trial.
Author:
Kienast, Joachim Beelen, D.W. Kolb, H.J. Schwerdtfeger, R. Arnold, R. Reichle, A. Holler, E. Staib, P. Sauerland, M.C. Berning, B. Schmid, C. Stelljes, M. Berdel, W.E. Hiddemann, W. Buchner, T.